XETRA •
Healthcare •
Biotechnology •
Quote as of 08/21/2026 17:35
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeXETRA
Market Capitalization48,100 mln
Float372 mln
Earnings Date07/31/2026
Piotroski F-Score
1
/ 9
Very weak
Beneish M-Score
-4.16
Highly reliable
Relative Strength
100
/ 100
Top performer
Debt / Equity
0.18
Very low leverage
ROE
-37.98
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Moderna is a biotechnology company founded in 2010 and based in Cambridge, Massachusetts, that develops medicines using messenger RNA technology. Its product portfolio spans vaccines for respiratory illnesses, viral infections, and bacterial diseases, as well as treatments for certain cancers and rare genetic conditions. The company works alongside prominent partners including Merck, Vertex Pharmaceuticals, the Bill & Melinda Gates Foundation, and OpenAI to advance its research and bring new treatments to patients around the world.
